Vibeke Sorensen Catts
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Vibeke Sorensen Catts has a total of 145 co-authors. Here are the top co-authors by number of shared publications:
- Perminder Singh Sachdev
University of New South Wales
6 shared publications - Henry Brodaty
Centre for Healthy Brain Ageing
3 shared publications - Marianne Nygaard
The Danish Twin Registry, Department of Public Health, University of Southern Denmark, Odense, Denmark
3 shared publications - Anbupalam Thalamuthu
University of New South Wales
2 shared publications - Kaare Christensen
The Danish Twin Registry, Department of Public Health, University of Southern Denmark, Odense, Denmark
2 shared publications - Lisbeth Aagaard Larsen
Danish Aging Research Center, University of Southern Denmark 6 Department of Public Health Odense
2 shared publications
Latest Publications
- Open Access
- 27 October 2026
- Published by Rockefeller University Press in Journal of Human Immunity
- Vol. 3 (1)
The rise in prevalence of autoantibodies neutralizing type I interferons reaches a plateau in centenarians
While autoantibodies (auto-Abs) neutralizing type I interferons (IFN-I) are relatively rare before the age of 65 (6% in individuals above 80 years in the general population. To assess the prevalence of IFN-I auto-Abs at the extreme end of human lifespan, we performed a multinational study of centenarians from four geographically and ethnically distinct cohorts collected in Denmark (n = 258), Colombia (n = 99), Australia (n = 281), and Japan (n = 300), comprising 938 individuals. Across cohorts, 51/938 centenarians (5.4%) harbored auto-Abs neutralizing IFN-I, ranging from 3.3% (Japan) to 9.1% (Colombia). We found that the prevalence of IFN-I auto-Abs levels off in centenarians compared with individuals ≥80 years from the general population, demonstrating that neutralizing IFN-I auto-Abs are not incompatible with longevity, despite conferring a risk of life-threatening viral infections. Yet, the plateau of their prevalence in centenarians suggests that they may not be beneficial for reaching exceptional longevity and may negatively impact mortality.
- 27 October 2026
- Published by Rockefeller University Press in Journal of Human Immunity
- Vol. 3 (1)
Open AccessThe rise in prevalence of autoantibodies neutralizing type I interferons reaches a plateau in centenarians
While autoantibodies (auto-Abs) neutralizing type I interferons (IFN-I) are relatively rare before the age of 65 (6% in individuals above 80 years in the general population. To assess the prevalence of IFN-I auto-Abs at the extreme end of human lifespan, we performed a multinational study of centenarians from four geographically and ethnically distinct cohorts collected in Denmark (n = 258), Colombia (n = 99), Australia (n = 281), and Japan (n = 300), comprising 938 individuals. Across cohorts, 51/938 centenarians (5.4%) harbored auto-Abs neutralizing IFN-I, ranging from 3.3% (Japan) to 9.1% (Colombia). We found that the prevalence of IFN-I auto-Abs levels off in centenarians compared with individuals ≥80 years from the general population, demonstrating that neutralizing IFN-I auto-Abs are not incompatible with longevity, despite conferring a risk of life-threatening viral infections. Yet, the plateau of their prevalence in centenarians suggests that they may not be beneficial for reaching exceptional longevity and may negatively impact mortality.
- Open Access
- 23 October 2026
- Published by Elsevier in SSRN Electronic Journal
Openness is associated with delayed dementia onset independently of plasma biomarkers
Some personality traits predict dementia risk, but it remains unclear whether these associations reflect differences in neurodegeneration or Alzheimer disease pathology, or whether personality modifies the clinical impact of such pathology. We examined associations between baseline personality traits (neuroticism, openness, conscientiousness), plasma biomarkers (glial fibrillary acidic protein, neurofilament light, phosphorylated tau 217), and time to incident dementia. Participants were 712 older adults (48% male, aged 71–91 years) from the Sydney Memory and Ageing Study, dementia-free at baseline. Incident dementia was diagnosed over a mean of 7.4 years (maximum 13.5 years). Linear models examined trait-biomarker associations. Accelerated failure time models examined time to dementia, with trait × biomarker interactions assessing cognitive resilience or vulnerability. Overall, 222 individuals developed dementia (42.2 per 1,000 person-years). No personality trait was associated with plasma biomarkers. Higher levels of all three biomarkers predicted shorter time to dementia (time ratio = 0.803–0.848, all p < 0.001). Neuroticism and conscientiousness were not associated with time to dementia, but higher openness predicted longer time to dementia after adjustment for biomarkers and covariates (time ratio = 1.079, 95% CI 1.006–1.159, p = 0.034). No significant personality × biomarker interactions were observed. In conclusion, the absence of associations between personality traits and biomarkers provides no evidence that the examined traits influence dementia risk through the measured biomarker levels or modify their association with dementia. However, higher openness was associated with delayed dementia onset independently of biomarkers, which may reflect cognitive reserve and related behavioural pathways warranting further investigation.
- 23 October 2026
- Published by Elsevier in SSRN Electronic Journal
Open AccessOpenness is associated with delayed dementia onset independently of plasma biomarkers
Some personality traits predict dementia risk, but it remains unclear whether these associations reflect differences in neurodegeneration or Alzheimer disease pathology, or whether personality modifies the clinical impact of such pathology. We examined associations between baseline personality traits (neuroticism, openness, conscientiousness), plasma biomarkers (glial fibrillary acidic protein, neurofilament light, phosphorylated tau 217), and time to incident dementia. Participants were 712 older adults (48% male, aged 71–91 years) from the Sydney Memory and Ageing Study, dementia-free at baseline. Incident dementia was diagnosed over a mean of 7.4 years (maximum 13.5 years). Linear models examined trait-biomarker associations. Accelerated failure time models examined time to dementia, with trait × biomarker interactions assessing cognitive resilience or vulnerability. Overall, 222 individuals developed dementia (42.2 per 1,000 person-years). No personality trait was associated with plasma biomarkers. Higher levels of all three biomarkers predicted shorter time to dementia (time ratio = 0.803–0.848, all p < 0.001). Neuroticism and conscientiousness were not associated with time to dementia, but higher openness predicted longer time to dementia after adjustment for biomarkers and covariates (time ratio = 1.079, 95% CI 1.006–1.159, p = 0.034). No significant personality × biomarker interactions were observed. In conclusion, the absence of associations between personality traits and biomarkers provides no evidence that the examined traits influence dementia risk through the measured biomarker levels or modify their association with dementia. However, higher openness was associated with delayed dementia onset independently of biomarkers, which may reflect cognitive reserve and related behavioural pathways warranting further investigation.
- Open Access
- 8 June 2026
- Published by Cambridge University Press (CUP) in Psychological Medicine
- Vol. 56, e182
The long reach of childhood income inequality: a multinational twin study of gene–environment interplay on adult depressive symptoms
Background: Living in a country with a large gap between high and low earners has been linked to poor health, including depression. Less studied is gene-by-environment interplay with income inequality as the environmental exposure. Here, we examine the association between childhood exposure to inequality and individual differences in adult depressive symptoms, testing for moderation of genetic influences by inequality using polygenic indices for major depressive disorder, as well as twin models. Methods: The research participants were 69,924 members of twin studies from four developed countries, born between 1893 and 1979, aged 22–103 years at depressive symptom assessment. Genotyping was available for 6,256 participants. Income inequality was operationalized as share of income accruing to the top 1% for each country when the participants were between age 5 and 15 years. Results: Childhood income inequality was associated with depressive symptom scores in adulthood, adjusting for covariates. Each 1% rise in inequality was associated with 0.295 higher depressive symptoms (scaled on T-score units). In genetic analyses, interaction effects showed that men who faced more inequality as children and had higher genetic risk for depression reported modestly higher depressive symptoms compared to other men. For women, both genetic risk and inequality mattered, with each independently associated with depressive symptoms. Twin models showed that inequality moderated genetic variance underlying depressive symptoms; heritability of depressive symptoms was higher where exposure to income inequality was higher. Conclusions: Findings illustrate the long reach of childhood exposure to income inequality and suggest that advantaged environments may help protect against the effects of deleterious genes.
- 8 June 2026
- Published by Cambridge University Press (CUP) in Psychological Medicine
- Vol. 56, e182
Open AccessThe long reach of childhood income inequality: a multinational twin study of gene–environment interplay on adult depressive symptoms
Background: Living in a country with a large gap between high and low earners has been linked to poor health, including depression. Less studied is gene-by-environment interplay with income inequality as the environmental exposure. Here, we examine the association between childhood exposure to inequality and individual differences in adult depressive symptoms, testing for moderation of genetic influences by inequality using polygenic indices for major depressive disorder, as well as twin models. Methods: The research participants were 69,924 members of twin studies from four developed countries, born between 1893 and 1979, aged 22–103 years at depressive symptom assessment. Genotyping was available for 6,256 participants. Income inequality was operationalized as share of income accruing to the top 1% for each country when the participants were between age 5 and 15 years. Results: Childhood income inequality was associated with depressive symptom scores in adulthood, adjusting for covariates. Each 1% rise in inequality was associated with 0.295 higher depressive symptoms (scaled on T-score units). In genetic analyses, interaction effects showed that men who faced more inequality as children and had higher genetic risk for depression reported modestly higher depressive symptoms compared to other men. For women, both genetic risk and inequality mattered, with each independently associated with depressive symptoms. Twin models showed that inequality moderated genetic variance underlying depressive symptoms; heritability of depressive symptoms was higher where exposure to income inequality was higher. Conclusions: Findings illustrate the long reach of childhood exposure to income inequality and suggest that advantaged environments may help protect against the effects of deleterious genes.
- 10 March 2026
- Published by Springer Nature in Nature Cities
- Vol. 3 (4) , 338-346
Neighborhood street connectivity and hippocampus volume in older adults
- 10 March 2026
- Published by Springer Nature in Nature Cities
- Vol. 3 (4) , 338-346
Neighborhood street connectivity and hippocampus volume in older adults
- Open Access
- 10 June 2025
- Published by Springer Nature in Nature Human Behaviour
- Vol. 9 (8) , 1683-1696
Genetics of monozygotic twins reveals the impact of environmental sensitivity on psychiatric and neurodevelopmental phenotypes
Individual sensitivity to environmental exposures may be genetically influenced. This genotype-by-environment interplay implies differences in phenotypic variance across genotypes, but these variants have proven challenging to detect. Genome-wide association studies of monozygotic twin differences are conducted through family-based variance analyses, which are more robust to the systemic biases that impact population-based methods. We combined data from 21,792 monozygotic twins (10,896 pairs) from 11 studies to conduct one of the largest genome-wide association study meta-analyses of monozygotic phenotypic differences, in children, adolescents and adults separately, for seven psychiatric and neurodevelopmental phenotypes: attention deficit hyperactivity disorder symptoms, autistic traits, anxiety and depression symptoms, psychotic-like experiences, neuroticism and wellbeing. The proportions of phenotypic variance explained by single-nucleotide polymorphisms in these phenotypes were estimated (h 2 = 0–18%), but were imprecise. We identified 13 genome-wide significant associations (single-nucleotide polymorphisms, genes and gene sets), including genes related to stress reactivity for depression, growth factor-related genes for autistic traits and catecholamine uptake-related genes for psychotic-like experiences. This is the largest genetic study of monozygotic twins to date by an order of magnitude, evidencing an alternative method to study the genetic architecture of environmental sensitivity. The statistical power was limited for some analyses, calling for better-powered future studies.
- 10 June 2025
- Published by Springer Nature in Nature Human Behaviour
- Vol. 9 (8) , 1683-1696
Open AccessGenetics of monozygotic twins reveals the impact of environmental sensitivity on psychiatric and neurodevelopmental phenotypes
Individual sensitivity to environmental exposures may be genetically influenced. This genotype-by-environment interplay implies differences in phenotypic variance across genotypes, but these variants have proven challenging to detect. Genome-wide association studies of monozygotic twin differences are conducted through family-based variance analyses, which are more robust to the systemic biases that impact population-based methods. We combined data from 21,792 monozygotic twins (10,896 pairs) from 11 studies to conduct one of the largest genome-wide association study meta-analyses of monozygotic phenotypic differences, in children, adolescents and adults separately, for seven psychiatric and neurodevelopmental phenotypes: attention deficit hyperactivity disorder symptoms, autistic traits, anxiety and depression symptoms, psychotic-like experiences, neuroticism and wellbeing. The proportions of phenotypic variance explained by single-nucleotide polymorphisms in these phenotypes were estimated (h 2 = 0–18%), but were imprecise. We identified 13 genome-wide significant associations (single-nucleotide polymorphisms, genes and gene sets), including genes related to stress reactivity for depression, growth factor-related genes for autistic traits and catecholamine uptake-related genes for psychotic-like experiences. This is the largest genetic study of monozygotic twins to date by an order of magnitude, evidencing an alternative method to study the genetic architecture of environmental sensitivity. The statistical power was limited for some analyses, calling for better-powered future studies.
- Open Access
- 30 September 2024
- Published by The Open Journal in Journal of Open Source Software
- Vol. 9 (101) , 6693
DataRepExp: a R shiny Application that makes Data FAIR for Data Repositories
- 30 September 2024
- Published by The Open Journal in Journal of Open Source Software
- Vol. 9 (101) , 6693
Open AccessDataRepExp: a R shiny Application that makes Data FAIR for Data Repositories
- Top Cited Papers
- 13 November 2023
- Published by Springer Nature in Nature Reviews Neurology
- Vol. 19 (12) , 737-753
Molecular biomarkers for vascular cognitive impairment and dementia
As disease-specific interventions for dementia are being developed, the ability to identify the underlying pathology and dementia subtypes is increasingly important. Vascular cognitive impairment and dementia (VCID) is the second most common cause of dementia after Alzheimer disease, but progress in identifying molecular biomarkers for accurate diagnosis of VCID has been relatively limited. In this Review, we examine the roles of large and small vessel disease in VCID, considering the underlying pathophysiological processes that lead to vascular brain injury, including atherosclerosis, arteriolosclerosis, ischaemic injury, haemorrhage, hypoperfusion, endothelial dysfunction, blood–brain barrier breakdown, inflammation, oxidative stress, hypoxia, and neuronal and glial degeneration. We consider the key molecules in these processes, including proteins and peptides, metabolites, lipids and circulating RNA, and consider their potential as molecular biomarkers alone and in combination. We also discuss the challenges in translating the promise of these biomarkers into clinical application.
- 13 November 2023
- Published by Springer Nature in Nature Reviews Neurology
- Vol. 19 (12) , 737-753
Top Cited PapersMolecular biomarkers for vascular cognitive impairment and dementia
As disease-specific interventions for dementia are being developed, the ability to identify the underlying pathology and dementia subtypes is increasingly important. Vascular cognitive impairment and dementia (VCID) is the second most common cause of dementia after Alzheimer disease, but progress in identifying molecular biomarkers for accurate diagnosis of VCID has been relatively limited. In this Review, we examine the roles of large and small vessel disease in VCID, considering the underlying pathophysiological processes that lead to vascular brain injury, including atherosclerosis, arteriolosclerosis, ischaemic injury, haemorrhage, hypoperfusion, endothelial dysfunction, blood–brain barrier breakdown, inflammation, oxidative stress, hypoxia, and neuronal and glial degeneration. We consider the key molecules in these processes, including proteins and peptides, metabolites, lipids and circulating RNA, and consider their potential as molecular biomarkers alone and in combination. We also discuss the challenges in translating the promise of these biomarkers into clinical application.